The Blue Pill and Big Pharma: A Dangerous Investment?

The performance of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial returns, the patent expiration in key markets has introduced considerable uncertainty . Investors are now grappling with the consequences of l

read more